Physicians' Academy for Cardiovascular Education

Protecting the heart and the kidney:

Slides (presentation) - May 28, 2011

Protecting the heart and the kidney:
Implications from the SHARP trial


Prof. Jane Armitage, MD
Clinical Trials Service Unit,
University of Oxford, United Kingdom

MC Lipid Innovations - Prague, ay 2011


SHARP study

SHARP concluded that around a quarter of all heart attacks, strokes, and operations to open blocked arteries could be avoided in people with chronic kidney disease by using the combination of ezetimibe and simvastatin to lower blood cholesterol levelsSharp Collaborative Group.  Am Heart J. 2010 Nov;160(5):785-794

Share this page with your colleagues and friends: